Catherine Wood's PRME Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 5.37 M shares of Prime Medicine, Inc. (PRME) worth $18.63 M, representing 0.12% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in PRME, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 3.16 M shares. Largest reduction occurred in Q1 2025, reducing 2.06 M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Prime Medicine (PRME) Holding Value Over Time
Track share changes against reported price movement
Quarterly Prime Medicine (PRME) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +1.64 M | New Buy | 1.64 M | $18.58 |
| Q1 2023 | +282,293 | Add 17.21% | 1.92 M | $12.30 |
| Q2 2023 | +526,922 | Add 27.41% | 2.45 M | $14.65 |
| Q3 2023 | +173,230 | Add 7.07% | 2.62 M | $9.54 |
| Q4 2023 | +515,841 | Add 19.67% | 3.14 M | $8.86 |
| Q1 2024 | +2.86 M | Add 90.98% | 5.99 M | $7.00 |
| Q2 2024 | +133,419 | Add 2.23% | 6.13 M | $5.14 |
| Q3 2024 | -466,054 | Reduce 7.61% | 5.66 M | $3.87 |
| Q4 2024 | -510,486 | Reduce 9.02% | 5.15 M | $2.92 |
| Q1 2025 | -2.06 M | Reduce 39.90% | 3.1 M | $1.99 |
| Q2 2025 | -772,503 | Reduce 24.96% | 2.32 M | $2.47 |
| Q3 2025 | +3.16 M | Add 135.84% | 5.48 M | $5.54 |
| Q4 2025 | -109,325 | Reduce 2.00% | 5.37 M | $3.47 |
Catherine Wood's Prime Medicine Investment FAQs
Catherine Wood first purchased Prime Medicine, Inc. (PRME) in Q4 2022, acquiring 1,639,984 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Prime Medicine, Inc. (PRME) for 13 quarters since Q4 2022.
Catherine Wood's largest addition to Prime Medicine, Inc. (PRME) was in Q3 2025, adding 5,477,851 shares worth $30.35 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 5,368,526 shares of Prime Medicine, Inc. (PRME), valued at approximately $18.63 M.
As of the Q4 2025 filing, Prime Medicine, Inc. (PRME) represents approximately 0.12% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Prime Medicine, Inc. (PRME) was 6,126,773 shares, as reported at the end of Q2 2024.